Literature DB >> 15454881

Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.

Hart P Garner1, James R Phillips, Jean G Herron, Susan J Severson, Carlos E Milla, Warren E Regelmann.   

Abstract

Excess neutrophils are present in the airways of patients with cystic fibrosis (CF). Myeloperoxidase (MPO) activity of acid extracts of sputum is directly correlated with airflow obstruction in CF patients. We hypothesized that the sputum MPO was derived from the MPO of neutrophils that entered the airways from the circulation. Active MPO without protease activity injures airways. If MPO activity from circulating neutrophils that emigrate into the airways of these patients causes increased airway epithelial permeability and mucus-gland secretion, then (1) those patients with greater MPO activity per circulating neutrophil would be more likely to produce sputum and (2) the MPO activity per circulating neutrophil would positively correlate with airflow obstruction. We determined the MPO activity for both circulating and sputum neutrophils. Spirometry and respiratory cultures were obtained simultaneously with blood and sputum samples. CF patients with more MPO activity within their circulating neutrophils were more likely to produce sputum ( P =.001, chi 2 test), and the MPO activity per circulating neutrophil was positively correlated with airflow obstruction as measured on the basis of the ratio of 1-second forced expiratory volume to forced vital capacity ( P <. 03, Kruskal-Wallace test). These associations were independent of age, sex, the results of respiratory-tract culture, or protease activity in the circulating neutrophils. MPO activity in circulating neutrophils from CF patients homozygotic for the deletion of phenylalanine at position 508 in the CF transmembrane regulator protein is directly related to the severity of these patients' pulmonary disease. Our results are consistent with the hypothesis that circulating neutrophils deliver active MPO to the airway, producing airway injury and airflow obstruction in homozygotic delF508 CF patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454881     DOI: 10.1016/j.lab.2004.04.010

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

Review 1.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.

Authors:  Aaron Roth; Sean Ott; Kelli M Farber; Teresa A Palazzo; Wayne E Conrad; Makhluf J Haddadin; Dean J Tantillo; Carroll E Cross; Jason P Eiserich; Mark J Kurth
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

3.  Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.

Authors:  Meenu Mishra; Adam Ressler; Larry S Schlesinger; Daniel J Wozniak
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

4.  Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.

Authors:  Dae-goon Yoo; Matthew Winn; Lan Pang; Samuel M Moskowitz; Harry L Malech; Thomas L Leto; Balázs Rada
Journal:  J Immunol       Date:  2014-04-16       Impact factor: 5.422

5.  Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.

Authors:  Wanda F Reynolds; Isabelle Sermet-Gaudelus; Valérie Gausson; Marie-Noëlle Feuillet; Jean-Paul Bonnefont; Gérard Lenoir; Béatrice Descamps-Latscha; Véronique Witko-Sarsat
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.

Authors:  Rachida Legssyer; François Huaux; Jean Lebacq; Monique Delos; Etienne Marbaix; Patrick Lebecque; Dominique Lison; Bob J Scholte; Pierre Wallemacq; Teresinha Leal
Journal:  Respir Res       Date:  2006-10-25

7.  Neutrophil extracellular trap release driven by bacterial motility: Relevance to cystic fibrosis lung disease.

Authors:  Balázs Rada
Journal:  Commun Integr Biol       Date:  2017-02-17

Review 8.  Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.

Authors:  Balázs Rada
Journal:  Pathogens       Date:  2017-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.